Conferences \ Nanoscitech2016 \ Sessions in Golden Jubilee Auditorium \ Agenda \ Rajendra Kumar |
Register | Login |
In Vitro Anticancer Activity Evaluation for Naringenin Nanoformulation on Triple Negative Breast Cancer Cell LineSaturday, 20 February 2016 at 12:45 Add to Calendar ▼2016-02-20 12:45:002016-02-20 13:45:00Europe/LondonIn Vitro Anticancer Activity Evaluation for Naringenin Nanoformulation on Triple Negative Breast Cancer Cell LineSELECTBIOenquiries@selectbiosciences.com |